Patents by Inventor Anna Power

Anna Power has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080108688
    Abstract: A Ramipril formulation which is suitably stabilised to control the degradation to the active metabolite ramiprilat.
    Type: Application
    Filed: October 29, 2007
    Publication date: May 8, 2008
    Applicant: Selamine Limited
    Inventors: Paul Harrison, Anna Power
  • Publication number: 20080108687
    Abstract: A Ramipril formulation which is suitably stabilised to control the degradation to the active metabolite ramiprilat.
    Type: Application
    Filed: October 29, 2007
    Publication date: May 8, 2008
    Applicant: Selamine Limited
    Inventors: Paul Harrison, Anna Power
  • Publication number: 20070259941
    Abstract: A Ramipril formulation which is suitably stabilised to control the degradation to the active metabolite ramiprilat.
    Type: Application
    Filed: November 15, 2005
    Publication date: November 8, 2007
    Applicant: Selamine Limited
    Inventors: Paul Harrison, Anna Power
  • Publication number: 20070098782
    Abstract: A Ramipril formulation which is suitably stabilised to control the degradation to the active metabolite ramiprilat.
    Type: Application
    Filed: August 24, 2006
    Publication date: May 3, 2007
    Applicant: Selamine Limited
    Inventors: Paul Harrison, Anna Power
  • Publication number: 20070065507
    Abstract: A bisphosphonate for treatment of osteoporosis is formulated with an amount of an antifoaming agent effective for reducing foaming in the stomach, leading to reduced reflux and oesophageal irritation in use and increased patient compliance.
    Type: Application
    Filed: May 24, 2006
    Publication date: March 22, 2007
    Applicant: Selamine LImited
    Inventors: Paul Harrison, Anna Power
  • Publication number: 20070053975
    Abstract: A Ramipril formulation rapidly disintegrates after ingestion and exhibits substantially no food effect.
    Type: Application
    Filed: August 24, 2006
    Publication date: March 8, 2007
    Applicant: Selamine Limited
    Inventors: Paul Harrison, Anna Power